These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
    Author: Ratzmann KP, Schulz B, Witt S, Ziegler M.
    Journal: Int J Obes; 1981; 5(2):163-9. PubMed ID: 7014481.
    Abstract:
    Pancreatic glucagon (IRG) and insulin (IRI) secretion patterns were studied in obese subjects with normal (n = 7), borderline (n = 5) and pathological carbohydrate tolerance (n = 11), as well as in 19 non-obese healthy controls without a family history of diabetes, by means of a 2-h glucose infusion (12 mg/kg/min), primed by an initial injection of 0.33 g/kg glucose. With regard to the insulin secretion all obese groups were characterized by a significant hyperinsulinaemia during the late secretion phase, whereas the early insulin response ( delta IRI-area 0-5 min) was significantly reduced in obesity with pathological carbohydrate tolerance. There was no significant differences in fasting IRG levels among controls (29.7 +/- 6.1 pmol/l) and pathological glucose tolerance (31.2 +/- 4.6 pmol/l). In addition, absolute IRG levels and the IRG concentration pattern during glucose infusion were comparable in all groups confirming no alpha-cell resistance to glucose suppression in obesity, irrespective of normal or impaired carbohydrate tolerance. The molar IRI-IRG ratio was significantly increased during glucose infusion in all obese groups reflecting a relative anabolic state. There were no correlations between IRG secretion and relative body weight, glucose tolerance or insulin response to glucose.
    [Abstract] [Full Text] [Related] [New Search]